The Expanding Role of Drug-Coated Balloons and Endothelial Dynamic Strain Assessment in the Treatment of De Novo Atherosclerotic Coronary Artery Disease

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The potential for drug-coated balloons (DCB) as a primary treatment for de novo atherosclerotic coronary artery disease in larger vessels requires more research. This study highlights the potential for DCB in various sized vessels. The thorough assessment of the target coronary vasculature through computer programs helps to compare coronary arteries and their lesions with the aim of assessing the impact of intervention.

The authors of this article theorize that the differences in elasticity of coronary arteries may explain the differences in acute luminal gain following DCB angioplasty. Although this study shows promise for the use of DCB in de novo lesions in larger coronary arteries, further randomized controlled trials are needed to assess their long-term efficacy and clinical significance.

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Mingze

Aiden Kenny and Faisal Sharif. The Expanding Role of Drug-Coated Balloons and Endothelial Dynamic Strain Assessment in the Treatment of De Novo Atherosclerotic Coronary Artery Disease. CVIA. 2024. Vol. 9(1). DOI: 10.15212/CVIA.2024.0048

CVIA Journal